List of works - Mattia Capulli

Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice.

scientific article published on May 2009

Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation.

scientific article

CRELD2 Is a Novel LRP1 Chaperone That Regulates Noncanonical WNT Signaling in Skeletal Development

scientific article published on 17 March 2020

Effective Small Interfering RNA Therapy to Treat CLCN7-dependent Autosomal Dominant Osteopetrosis Type 2.

scientific article published on September 2015

Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications

scientific article published on 11 June 2019

Generation and culture of osteoclasts

scientific article

Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models

scientific article

Global transcriptome analysis in mouse calvarial osteoblasts highlights sets of genes regulated by modeled microgravity and identifies a "mechanoresponsive osteoblast gene signature".

scientific article

Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs

scientific article

Interleukin-1β, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk.

scientific article published on 19 July 2016

Lipocalin 2: a new mechanoresponding gene regulating bone homeostasis

scientific article published on 01 February 2015

Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans

scientific article

Osteoblast and osteocyte: games without frontiers.

scientific article published on 14 May 2014

The C-terminal domain of chondroadherin: a new regulator of osteoclast motility counteracting bone loss

scientific article published in August 2014

The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis

scientific article

The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: a preclinical study

scientific article published on 18 December 2014

Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression

scientific article

List of works by Mattia Capulli

Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice.

Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation.

CRELD2 Is a Novel LRP1 Chaperone That Regulates Noncanonical WNT Signaling in Skeletal Development

Effective Small Interfering RNA Therapy to Treat CLCN7-dependent Autosomal Dominant Osteopetrosis Type 2.

Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications

Generation and culture of osteoclasts

Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models

Global transcriptome analysis in mouse calvarial osteoblasts highlights sets of genes regulated by modeled microgravity and identifies a "mechanoresponsive osteoblast gene signature".

Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs

Interleukin-1β, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk.

Lipocalin 2: a new mechanoresponding gene regulating bone homeostasis

Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans

Osteoblast and osteocyte: games without frontiers.

The C-terminal domain of chondroadherin: a new regulator of osteoclast motility counteracting bone loss

The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis

The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: a preclinical study

Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression